Intuitive Surgical’s (ISRG) story is improving. A new product was developed as an upgrade to its da Vinci Surgical System. Furthermore, the company enjoys a virtual monopoly in robotic surgery without direct competition.

The company’s razor/razor blade business model ensures recurring revenues even during difficult times. In the third quarter, earnings of $1.64 per share were higher than the Zacks Consensus Estimate of $1.45. Revenue growth was witnessed across all the segments.

However, we believe there is limited upside potential for the stock at current levels. As such, we are downgrading the stock to Neutral with a target price of $320.

Zacks Investment Research

1. (IART) Integra LifeSciences Holdings Earns New ContractIntegra LifeSciences Holdings Corporation (IART) recently announced that it has signed a new three-year contract...
2. (ISRG) Intuitive Surgical Enters JapanIntuitive Surgical, Inc. (ISRG) recently received regulatory approval from the Japanese Ministry of Health, Labor...
3. (ISRG) Intuitive Surgical Inc. – Earnings Estimates RisingIntuitive Surgical, Inc. (ISRG) Growing Revenue Intuitive announced quarterly results on the 20th of October...
4. (ISRG) Intuitive Surgical Beats Consensus EstimatesIntuitive Surgical, Inc. (ISRG) reported a third quarter net income of $1.55 per share, which...
5. (ISRG) Intuitive Surgical- Is the Bull of the DayIntuitive Surgical’s (ISRG) story is improving. A new product was developed as an upgrade to...
6. (ISRG) Intuitive Surgical Inc. – net profit margin of 22% is roughly 7 times the industry norm of just 35Intuitive Surgical, Inc. (ISRG) bolstered its balance sheet, blew away estimates, and investors cant get...

Search Posts by Tag: Intuitive Surgical Inc | ISRG | Healthcare | Medical Appliances & Equipment

RSS Feeds by Tag: Intuitive Surgical Inc | ISRG | Healthcare | Medical Appliances & Equipment |

Other Posts by: vitalstocks | RSS Feed for this author